NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Jan 22, 2016 $15.42 $15.42 $15.42 $15.42 752 200
Jan 21, 2016 $13.43 $13.43 $13.43 $13.43 224 100
Jan 20, 2016 $14.63 $14.63 $14.63 $14.63 124 400
Jan 19, 2016 $13.89 $13.89 $13.89 $13.89 123 600
Jan 15, 2016 $13.89 $13.89 $13.89 $13.89 155 700
Jan 14, 2016 $14.41 $14.41 $14.41 $14.41 185 700
Jan 13, 2016 $14.40 $14.40 $14.40 $14.40 152 700
Jan 12, 2016 $15.84 $15.84 $15.84 $15.84 119 000
Jan 11, 2016 $15.81 $15.81 $15.81 $15.81 317 500
Jan 08, 2016 $16.67 $16.67 $16.67 $16.67 113 700
Jan 07, 2016 $17.24 $17.24 $17.24 $17.24 108 400
Jan 06, 2016 $17.86 $17.86 $17.86 $17.86 460 600
Jan 05, 2016 $18.16 $18.16 $18.16 $18.16 164 000
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT